The effect of Montelukast and Gabapentin on pruritus in hemodialysis patients
Phase 3
- Conditions
- Dialysis patients.Unspecified complication of foreign body accidentally left in body following kidney dialysisT81.502
- Registration Number
- IRCT20180617040114N3
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients diagnosed with chronic renal failure
Equal number of dialysis sessions per week
Do not take itching drugs
Perform hemodialysis for at least 6 months
Exclusion Criteria
Having skin diseases
Patients whose hemodialysis has been stopped for any reason or is on the kidney transplant list
Lack of uremic pruritus
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pruritus rate. Timepoint: It is measured one day before the intervention and 8 weeks after the intervention. Method of measurement: Using Visual analogue scale questionnaire.
- Secondary Outcome Measures
Name Time Method